Tracks 8

Optimizing Addiction Medicine RCTs in the Developing World

Randomized controlled trials (RCTs) are the gold standard for testing the safety and comparative effectiveness of treatments for substance use disorders (SUDs). Yet, many regions of the developing world—as well as minoritized communities in North America and Europe—are underrepresented in large, multi-centre RCTs in addiction medicine. Given these limitations, we bring together leading global experts …

Optimizing Addiction Medicine RCTs in the Developing World Read More »

Induction onto Buprenorphine utilizing transdermal patches over 24-48 hours: IPPAS method

Introduction/Objectives: Opioid agonist treatment (OAT) is essential for managing opioid use disorder (OUD), with buprenorphine being a preferred treatment due to its safer profile. However, its partial agonism at the mu-opioid receptor can lead to precipitated withdrawal, complicating the induction process. Innovative protocols have been developed to minimize withdrawal during induction. Our team previously reported …

Induction onto Buprenorphine utilizing transdermal patches over 24-48 hours: IPPAS method Read More »

Evidence-Based Practices in Assessments and Interventions for Cognitive Deficits as Substance Use Disorder Comorbidities

1. Cue-Exposure Combined with Episodic Future Thinking for Treatment of Opioid Use Disorder – Tara Rezapour (USA) 2. Stepped Care Based Optimisation of Cognitive Remediation in Addiction – Antonio Verdejo-Garcia (Australia) 3. New Developments in Cognitive Bias Modification for Addiction – Reinout W. Wiers (Netherlands) 4. The Alcohol and Drug Cognitive Enhancement (ACE) suite of …

Evidence-Based Practices in Assessments and Interventions for Cognitive Deficits as Substance Use Disorder Comorbidities Read More »

Healthcare service utilization among individuals diagnosed with alcohol use disorders: New insights from the PRAGMA study

1. Patient Routes of People with Alcohol Use Disorders in Germany (PRAGMA): A data linkage study – Bernd Schulte (Germany) 2. Severity of alcohol use disorder in electronic health records – Jakob Manthey (Germany) 3. Guideline-compliant care: Differences in hospitalization rates in people with and without post-acute treatment after qualified withdrawal – Ludwig Kraus (Germany) …

Healthcare service utilization among individuals diagnosed with alcohol use disorders: New insights from the PRAGMA study Read More »

Ground reality of Growing Digital Media Misuse among South-Asian children – Findings of In-depth Focus Group Discussions with Key Stakeholders

1. Study design and objectives for the FGDs with key stakeholders – Renjith R Pillai (India) 2. Findings from FGDs with Teachers Exploring their Perspectives on Digital Media Misuse Among Private School children – Devender Kumar (India) 3. Findings from FGDs with Teachers Exploring their Perspectives on Digital Media Misuse Among Publicly Funded School Children …

Ground reality of Growing Digital Media Misuse among South-Asian children – Findings of In-depth Focus Group Discussions with Key Stakeholders Read More »

Innovative Brain Circuitry Targets for Addiction Treatment

1. Independent Evaluation of Combo-Stim DBS in Relapse Prevention for Heroin Dependence and Pilot Study for Treatment-Resistant Alcohol Dependence – Wei Hao (China) 2. Frontopolar Cortex as a Target for Neuromodulation in Addiction Treatment – Samir Kumar Praharaj (India) 3. Targeting the Dorsolateral Prefrontal Cortex with Brain Stimulation for Addiction Treatment: From Traditional to Modern …

Innovative Brain Circuitry Targets for Addiction Treatment Read More »

Improving Addiction Care with Telemedicine, Gambling diagnosis screening, Machine Learning, and Positive Language

1. Telemedicine-assisted Buprenorphine induction versus standard of care: a randomised controlled, non-inferiority trial. – Harpreet Singh Dhillon 2. Diagnoses of gambling disorder in the Finnish social- and healthcare system: a register-based study – Niklas Tapani Mäkelä 3. The positive impact of a short training for physicians on the use of respectful language towards patients with …

Improving Addiction Care with Telemedicine, Gambling diagnosis screening, Machine Learning, and Positive Language Read More »

Challenges and Innovations in Pharmacological Treatment for ADHD and of Stimulant Use Disorders

1. Discontinuation and reinitiation of pharmacological treatment for ADHD medication among young people with comorbid ADHD and substance use disorder (SUD) – Andrea Johansson Capusan 2. Medical Hazards of Stimulant use Disorder – Soheir Helmy Elghonemy 3. Combination oral naltrexone/bupropion for methamphetamine use disorder, an open-label pilot study – Nicholas Lintzeris

Scroll to Top